Aeterna Zentaris Reports Second Quarter 2020 Financial Results and Provides Business Update
August 06, 2020 08:35 ET
|
Aeterna Zentaris Inc
– Positive results from AEZS-130-P01 (“Study P01”) confirmed dosing regimen of macimorelin as a potential diagnostic for childhood-onset growth hormone deficiency – Safety and efficacy...